Related Experiment Video
Updated: Aug 5, 2026
09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Breaking Through Cancer Pain: From Single-Drug Management to Multimodal Analgesia
Yating Xu1,2,3, Shu Xu1,2,3, Bo Huang1,2,3
1Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese, Medical University, Huzhou, Zhejiang, China, gumed.edu.pl.
Pain Research & Management
|July 31, 2026
Summary
Managing cancer pain remains challenging, with new treatments like novel analgesics and advanced interventions showing promise. Further research is needed to validate these therapies for effective, personalized cancer pain control.
Area of Science:
- Oncology
- Pain Management
- Pharmacology
Background:
- Cancer pain impacts 60-80% of advanced cancer patients, with 30% experiencing inadequate pain control.
- The World Health Organization (WHO) analgesic ladder improved management, but challenges like inadequate analgesia and opioid side effects persist.
Purpose of the Study:
- To review recent advancements in cancer pain management.
- To provide clinicians and researchers with updated insights on novel therapies.
Main Methods:
- Narrative review of recent literature.
- Evaluation of novel analgesics, opioid formulations, nanomedicine, invasive interventions, and integrative therapies.
Main Results:
- Novel analgesics, improved opioid delivery, and nanomedicine show preclinical promise.
- Invasive interventions (intrathecal delivery, neuromodulation, neurolysis) offer targeted options for refractory pain.
- Integrative therapies may improve quality of life, but direct analgesic evidence is limited.
Conclusions:
- Cancer pain management is moving towards personalized, multimodal approaches.
- Many new therapies require further cancer-specific validation.
- High-quality trials are essential for evidence-based precision cancer pain management.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...